Clinical Trial

Ablative Carbon Ion Radiotherapy With Pencil Beam Scanning for Locally Advanced Unresectable Pancreatic Cancer

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 7, 2023 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study is to investigate the clinical efficacy and safety of ablative carbon ion radiotherapy for locally advanced unresectable pancreatic cancer with pencil beam scanning and simultaneous integrated boost (SIB) technology.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-06-15; most recent amendment 2023-11-30.
Status change: Not Yet Recruiting → Recruiting 2023-11-30
Trial Details
NCT Number NCT05424159
Lead Sponsor Shanghai Proton and Heavy Ion Center
Conditions Pancreatic Cancer Non-resectable
Enrollment 48 participants
Start Date 2022-07-01
Primary Completion 2025-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2023-12-07